Prospects for Creation of Cardioprotective and Antiarrhythmic Drugs Based on Opioid Receptor Agonists / L. N. Maslov [et al.]

Уровень набора: Medicinal Research ReviewsАльтернативный автор-лицо: Maslov, L. N., Leonid Nikolaevich;Khaliulin, I. G., Igor Germanovich;Oeltgen, P. R., Peter;Naryzhnaya, N. V., Nataliya Vladimirovna;Pei Jian-Ming;Brown Stephen;Lishmanov, Yu. B., specialist in the field of medical technology, lead engineer aof Tomsk Polytechnic University, doctor of medical sciences, 1951-, Yury Borisovich;Downey, J. M., JamesКоллективный автор (вторичный): Национальный исследовательский Томский политехнический университет (ТПУ), Физико-технический институт (ФТИ), Лаборатория № 31 ядерного реактора (Лаборатория № 31 ЯР)Язык: английский.Страна: .Резюме или реферат: It has now been demonstrated that the µ, δ 1, δ 2, and K 1 opioid receptor (OR) agonists represent the most promising group of opioids for the creation of drugs enhancing cardiac tolerance to the detrimental effects of ischemia/reperfusion (I/R). Opioids are able to prevent necrosis and apoptosis of cardiomyocytes during I/R and improve cardiac contractility in the reperfusion period. The OR agonists exert an infarct-reducing effect with prophylactic administration and prevent reperfusion-induced cardiomyocyte death when ischemic injury of heart has already occurred; that is, opioids can mimic preconditioning and postconditioning phenomena. Furthermore, opioids are also effective in preventing ischemia-induced arrhythmias..Примечания о наличии в документе библиографии/указателя: [References: p. 905-922 (333 tit.)].Аудитория: .Тематика: электронный ресурс | труды учёных ТПУ | opioids | опиоиды | ишемия | реперфузия Ресурсы он-лайн:Щелкните здесь для доступа в онлайн
Тэги из этой библиотеки: Нет тэгов из этой библиотеки для этого заглавия. Авторизуйтесь, чтобы добавить теги.
Оценка
    Средний рейтинг: 0.0 (0 голосов)
Нет реальных экземпляров для этой записи

Title screen

[References: p. 905-922 (333 tit.)]

It has now been demonstrated that the µ, δ 1, δ 2, and K 1 opioid receptor (OR) agonists represent the most promising group of opioids for the creation of drugs enhancing cardiac tolerance to the detrimental effects of ischemia/reperfusion (I/R). Opioids are able to prevent necrosis and apoptosis of cardiomyocytes during I/R and improve cardiac contractility in the reperfusion period. The OR agonists exert an infarct-reducing effect with prophylactic administration and prevent reperfusion-induced cardiomyocyte death when ischemic injury of heart has already occurred; that is, opioids can mimic preconditioning and postconditioning phenomena. Furthermore, opioids are also effective in preventing ischemia-induced arrhythmias.

Для данного заглавия нет комментариев.

оставить комментарий.